Ligand validation:2YIP

YIO: 1-thio-beta-D-galactopyranose

YIO is a Ligand Of Interest in 2YIP designated by the RCSB

	Best-fitted instance in this entry
	Other instances in this entry

	Best-fitted instance in this entry
	Best-fitted PDB instances with same target (top 5)

	Best-fitted instance in this entry
	Best-fitted PDB instances with different target (top 5)

Identifier	Ranking for goodness of fit	Ranking for geometry	Real space R factor	Real space correlation coefficient	RMSZ-bond-length	RMSZ-bond-angle	Outliers of bond length	Outliers of bond angle	Atomic clashes	Stereochemical errors	Model completeness	Average occupancy
2YIP_YIO_E_1135	11%	10%	0.279	0.799	1.47	2.79	3	5	0	0	100%	0.7
2YIP_YIO_C_1135	10%	9%	0.274	0.78	2.26	2.15	2	7	1	0	100%	0.7
2YIP_YIO_B_1135	8%	7%	0.275	0.749	2.07	2.79	2	6	0	0	100%	0.8
2YIP_YIO_F_1135	4%	3%	0.299	0.688	1.98	3.86	3	6	1	0	100%	0.8
2YIP_YIO_A_1135	3%	3%	0.389	0.717	2.8	3.55	3	10	1	0	100%	0.9
2YIP_YIO_D_1135	3%	5%	0.382	0.709	1.75	3.49	3	6	0	0	100%	0.7
2YIO_YIO_A_1141	10%	7%	0.273	0.784	1.58	3.24	2	5	0	0	100%	0.7
8OJM_YIO_A_302	97%	78%	0.062	0.975	0.33	0.56	-	-	0	0	100%	1
8OJK_YIO_A_301	95%	73%	0.07	0.974	0.35	0.7	-	-	0	0	100%	1
8OJO_YIO_A_305	93%	63%	0.076	0.972	0.54	0.87	-	1	0	0	100%	1
8OJI_YIO_A_303	89%	86%	0.081	0.96	0.2	0.51	-	-	0	0	100%	1

RCSB PDB Core Operations are funded by the U.S. National Science Foundation (DBI-2321666), the US Department of Energy (DE-SC0019749), and the National Cancer Institute, National Institute of Allergy and Infectious Diseases, and National Institute of General Medical Sciences of the National Institutes of Health under grant R01GM133198.